Dec 23, 2022, 09:15 AM by

Dec 22, 2022, 01:00 AM by User Not Found

Bio-IT World | Funding for targeted cancer treatment AI platform, oligo-conjugated antibodies and nucleic acid-encoded pixels to identify and spatially locate cell surface proteins, life sciences SaaS solutions, and more.

Dec 21, 2022, 01:00 AM by User Not Found

Bio-IT World | A key member of the team that discovered the BRCA2 breast cancer susceptibility gene in 1995 is now enamored of the idea of taking on cancer with synthetic lethal therapies, a nontraditional approach that exploits the weaknesses of cancer cells. The promise of the treatment concept was the topic of the Heath Memorial Award keynote address delivered at the recent Leading Edge of Cancer Research Symposium of the University of Texas MD Anderson Cancer Center.

Dec 20, 2022, 12:31 PM by

Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, celebrated a successful year of achievements with its continuous temperature monitoring solution TempTraq®. Numerous studies were released this year showing the positive impact of TempTraq in oncology clinical trials and outpatient settings.

Dec 20, 2022, 01:00 AM by User Not Found

Bio-IT World | When sent electrical signals, a living model of the brain succeeded in “playing” Pong, a simple, tennis-like computer game popular in the 1970s. It was a notable feat for a single layer of neural cells in a dish, recapitulating how a real brain functions better than a computer or artificial intelligence ever will.

Dec 19, 2022, 12:21 PM by

Arloid Automation welcomes the new partnership between the UK and the USA (announced December 2022) to drive down energy prices but really it’s a reduction in energy consumption that’s needed to meet demand in 2023.

Dec 19, 2022, 12:12 PM by

Creative Biolabs identifies a suite of exosome services to advance basic research based on microRNAs-associated extracellular vesicles as novel diagnostic tools for melanoma.

Dec 19, 2022, 12:10 PM by

OncoDxRx scientists has described the combination of NGS and PGA as ‘world beating’ offering that will complete the test menu and benefit entire population of cancer patients.

Dec 16, 2022, 09:51 AM by

Integrated Synthesis-to-Clinic® Program Will Support HTD1801’s Clinical Development and Regulatory Submission Package

Dec 16, 2022, 01:00 AM by User Not Found

Bio-IT World | The rush to digitalization has been underway for some time, but there is one industry that remains stuck in the past: the life sciences. While there have been numerous advancements in the way drugs are developed, lab work continues to be dominated by out-of-date processes. Improving them isn’t going to move the dial. While they may help, they are not capable of producing the level of innovation that’s needed to take us to the next phase.

Dec 15, 2022, 09:59 AM by

New evidence demonstrates that NoriZite creates a physical barrier to prevent viral infection

Dec 15, 2022, 09:59 AM by

physIQ today announced a novel approach to estimating maximum oxygen utilization (VO2Max) using wearable biosensors and deep neural network technology. This innovative biomarker, eVO2Max, can be generated using 24 hours of continuous vital signs and activity data captured during routine daily activities. This enables remote assessment at higher frequency and convenience than by in-clinic tests of cardiopulmonary functional capacity, such as the gold standard, cardiopulmonary exercise test (CPET), and the less accurate surrogate six-minute walk test (6MWT).

Dec 15, 2022, 01:01 AM by User Not Found

Bio-IT World | During a recent virtual unveiling party livestreamed from around the world, Insilico Medicine introduced the latest updates to Pharma.AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials. Among the highlights were the addition of a knowledge graph to target discovery product PandaOmics and numerous new panels to generative chemistry engine Chemistry42.

Dec 15, 2022, 01:00 AM by User Not Found

Bio-IT World | During a recent virtual unveiling party livestreamed from around the world, Insilico Medicine introduced the latest updates to Pharma.AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials. Among the highlights were the addition of a knowledge graph to target discovery product PandaOmics and numerous new panels to generative chemistry engine Chemistry42.

Dec 14, 2022, 15:18 PM by

PubHive Navigator’s Fetch version 2.0 features new content curator and consumer roles, expanded data input and output options, integration capabilities, plus a simplified consumer user interface

Dec 14, 2022, 10:08 AM by

Form Bio, the breakthrough computational life sciences platform, today announced the integration of the NVIDIA Clara Parabricks suite of genomic analysis tools with Form Bio’s genomic analysis workflows. The integrated solution, provided by Form Bio, enables scientists, bioinformaticians and other life science professionals to execute genomic workflows with acceleration fueled by GPU parallelization and deep learning AI tools.

Dec 14, 2022, 10:08 AM by

Company focused on creating shot-free future of vaccines and expanding vaccine access; first human trial of Vaxess patch-based influenza vaccine showed strong safety and immunogenicity profiles

Dec 14, 2022, 10:08 AM by

InSysBio launches the Oncology version of Immune Response Template (IRT). IRT in Oncology represents a QSP platform of immune system in cancer, simultaneously being a tool for development of QSP and mechanistic models related to tumor-specific immune response.

Dec 14, 2022, 10:05 AM by

New innovation delivers optimal product conditions in fewer runs, reducing raw materials costs, and shaving weeks off of Process Development campaigns

Dec 14, 2022, 09:48 AM by

Qlucore will be participating in a major EU project that is working to improve preventative treatment for patients at risk of cardiovascular diseases, such as heart attacks and strokes.